Risk-Adapted Optimization of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2–Positive Early-Stage Breast Cancer
Year: 2026
Type: article
Source: Journal of Clinical Oncology
DOI: 10.1200/jco-26-01423
Authors: Sam O. Kleeman, Vered Stearns
Institution: Weill Cornell Medicine
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7212063870